Torren Management’s MediWound MDWD Stock Holding History

Torren Management’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24	Closed	-$443	–	1252
2025 Q4	$443	Buy	+24	New	+$439	﹤0.01%	1355

Other funds holding MDWD

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Torren Management's MDWD Position: Q1 2026 in Review

Torren Management sold out of MediWound (MDWD) in Q1 2026, closing a stake of 24 shares — an estimated $443 sold.

Torren Management first reported a position in MDWD in Q4 2025 and held it in 1 quarter. The position peaked at $443 in Q4 2025. 76 funds tracked by Wall St. Rank hold MDWD as of Q1 2026.

Torren Management reported no remaining MediWound position as of Q1 2026 after selling out during the quarter.
Torren Management sold 24 MediWound shares in Q1 2026, an estimated $443.
Torren Management first reported a position in MediWound in Q4 2025 and held it in 1 quarter.
Torren Management's MediWound position peaked at $443 in Q4 2025.
76 funds tracked by Wall St. Rank held MediWound as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.